强化母乳使用的围产和实验室决定因素:一个病例控制研究
C B G Tavares1, J M V Zacarias1,2, V H Souza3
1Programa de Pós-Graduação em Biociências e Fisiopatologia, Universidade Estadual de Maringá, Maringá, PR, Brasil.
概括
用FM85®强化母乳在出生时体重低,头周长改变或剖腹产的非常早产婴儿中更为常见. 强化并没有显著改变大多数实验室值,但可能提供一种生理替代方案.
科学领域:
- 新生儿科学 新生儿科学
- 儿童营养学 儿童营养学
- 婴儿免疫学 婴儿免疫学
背景情况:
- 过早出生的婴儿,特别是低出生体重 (LBW) 的婴儿,需要专门的营养支持.
- 人母乳 (HM) 强化在新生儿重症监护室 (NICU) 常见,以满足早产婴儿的高营养需求.
- 特定强化剂,如FM85®,对LBW早产婴儿的实验室参数和围产因素的影响需要进行调查.
研究的目的:
- 为了比较早产婴儿接受非强化HM和接受FM85®强化HM的婴儿之间的围产和实验室因素.
- 为了确定与使用HM强化在LBW早产婴儿中相关的围产特征.
- 评估HM强化对LBW早产婴儿实验室值的影响.
主要方法:
- 一项涉及38名LBW早产婴儿在NICU的病例控制研究.
- 围产期变量 (妊娠年龄,出生体重,头周长,分娩方式) 和实验室值的分析.
- 统计分析包括千平方测试,学生的t测试,克鲁斯卡尔-瓦利斯测试和曼-惠特尼测试.
主要成果:
- 非常早产的婴儿,那些患有LBW,体重进展不佳,头周长变化和剖腹产的婴儿更有可能接受FM85®强化.
- 中性粒细胞数量下降,而淋巴细胞数量在两组中都增加.
- 红细胞和血红蛋白水平恶化;在两组中,和水平显著增加.
- 用FM85®强化HM并没有显著改变大多数实验室值,除了红细胞计数.
结论:
- 低腰,头周长变化和剖腹产与使用HM强化剂的可能性增加有关.
- 在早产婴儿中观察到免疫学变化,不论强化.
- 像FM85®这样的同类强化剂可能代表LBW早产婴儿的更生理的营养方法.
更多相关视频
09:36Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers
Published on: July 28, 2022
1.8K
04:16Individualized Reconstitution of Human Milk Microbiota: A Feasible Approach in Real-World Settings
Published on: February 7, 2025
1.0K
相关概念视频
Development of Human Microbiota
68
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
68
Development of the Oral Microbiota
73
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
73
